LONDON  – Global law firm Reed Smith has advised Global Healthcare Opportunities (GHO Capital) a European specialist investor in healthcare, on its investment in FairJourney Biologics (FairJourney).

GHO Capital has partnered with the founding management team in FairJourney, a leader in providing antibody discovery services to global biopharma, to provide further capital, sector expertise and international network to build on FairJourney’s unique market position.

The significant transaction will support both organisations in their shared goal of becoming a global leader in the outsourced discovery and development of biologics.

The Reed Smith team was led in London by Life Sciences transactional partner Iqbal Hussain, supported by Global Corporate Group partners Mark Pedretti and Wayne Uffleman, tax partner Gareth Amdor and associates, James Hatchard (Corporate), Alia Khalil (Tax) and counsel Carl De Cicco (Employment).